- Report
- May 2024
- 130 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- April 2025
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- March 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Report
- July 2023
- 129 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2024
- 87 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Book
- February 2024
- 592 Pages
Fluvoxamine is a medication used to treat mental disorders such as obsessive-compulsive disorder (OCD), depression, and anxiety. It is a selective serotonin reuptake inhibitor (SSRI) and is available in both immediate-release and extended-release formulations. Fluvoxamine is generally well-tolerated and has few side effects. It is available in generic form and is also sold under the brand name Luvox.
The market for mental disorder drugs is highly competitive, with many different medications available to treat a variety of conditions. Fluvoxamine is one of the most commonly prescribed SSRIs, and is used to treat a wide range of mental health issues. It is often prescribed as a first-line treatment for OCD, and is also used to treat depression and anxiety.
The market for Fluvoxamine is highly competitive, with many different companies offering the medication. Some of the companies in the market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more
